ASH, American Society of Hematology 46th Annual Meeting

 

Konferenční abstrakta

Konferenční abstrakta z letošního kongresu ASH jsou uveřejněna na stránkách ASH. K prohledávání konferenčních abstrakt je třeba se nejprve zaregistrovat. Registrace je zdarma. Abstrakta lze prohledávat podle autorů, konferenčních dní, názvů příspěvků, klíčových slov a kategorií.

 

©2004 The American Society of Hematology and Marathon Multimedia. Přečtěte si, prosím, podmínky užití informací obsažených na konferenčních stránkách ASH ("Terms Use Agreement")

Aktivní účast z České republiky na ASH 2004:

1.	R. Pytlik, K. Kubackova, T. Kozak, D. Belada, J. Pirnos, M. Jankovska, J. Pukyova, T. Papajik, H. Siffnerova, P. Zak, I. Vasova, M. Hamouzova, M. Trneny [1322] Favorable Outcome of High-Risk Mediastinal Diffuse Large B-Cell Lymphoma (DLBCL) after Dose-Intensive Chemotherapy, Rituximab and Autologous Transplant (ASCT). Session Type: Poster Session 476-I Date/Time: Saturday, December 4, 2004 - 06:00 PM Session Info: Poster Session: Hodgkin's Lymphoma - Chemotherapy and Rituximab Combinations for Non-Hodgkin's Lymphomas (6:00 PM-7:30 PM)
2.	Marek Trneny, Jana Salkova, Josef Karban, Jan Cerny, Kyra Michalova, Jan Stritesky, Jiri Schwarz, Robert Pytlik, Alena Slavickova [3480] Rituximab, Fludarabin and Cyclophosphamide Followed by High Dose Therapy with Autologous Stem Cell Rescue Leads to High Molecular Remission Rate in Chronic Lymphocytic Leukemia Patients but Relapses Are Observed. Session Type: Poster Session 750-III Date/Time: Monday, December 6, 2004 - 05:30 PM Session Info: Poster Session: Novel Therapeutic Approaches to CLL (5:30 PM-7:00 PM)
3.	Dana Dvorakova, Stanislava Koskova, Martina Vodinska, Ales Hampl, Jiri Mayer, Petr Dvorak [4168] Fibroblast Growth Factor Receptors in Human Embryonic Stem Cells. Session Type: Publication Only Session Info: Publication Only
4.	Tomas Buchler, Marta Krejci, Adam Svobodnik, Zdenek Adam, Jiri Minarik, Jaroslav Bacovsky, Vlastimil Scudla, Jiri Mayer, Jiri Vorlicek, Roman Hajek [944] Angiotensin-I Converting Enzyme Inhibitors and the Survival of Patients with Multiple Myeloma Treated by Autologous Stem Cell Transplantation. Session Type: Poster Session 98-I Date/Time: Saturday, December 4, 2004 - 06:00 PM Session Info: Poster Session: Autologous Transplantation in Multiple Myeloma and Amyloidosis (6:00 PM-7:30 PM)
5.	Edgar Faber, Robert Pytlik, Marek Trneny, Jiri Slaby, Tomas Kozak, Ludek Raida, Tomas Papajik, Eva Zikesova, Jana Zapletalova, Ivana Maresova, Michaela Hamouzova, Karel Indrak [2925] A Single Dose of G-CSF after Autologous Stem Cell Transplantation in Patients with Malignant Lymphoma - Third Interim Analysis of Multicentre Randomized Trial Comparing Standard Schedule with Delayed Application and Placebo. Session Type: Poster Session 195-III Date/Time: Monday, December 6, 2004 - 05:30 PM Session Info: Poster Session: Clinical Results of Autologous Transplantation (5:30 PM-7:00 PM)
6.	Edgar Faber, Marie Jarosova, Jitka Nausova, Marie Holzerova, Svatopluk Skranc, Vladimir Divoky, Karel Indrak [4657] Intermittent Dosage of Imatinib - a Feasible Strategy for Patients with Significant Hematologic Toxicity during Standard Therapy. Session Type: Publication Only Session Info: Publication Only
7.	Ester Mejstrikova, Drago Batinic, Dubravcic Klara, Margareth Ng, Yonna Leung, Janos Kappelmayer, Drorit Luria, Shai Izraeli, Tomas Kalina, Martina Vaskova, Eva Fronkova, Jan Stary, Jan Trka, Ondrej Hrusak [1092] Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia by 4color Cytometry in International Multicenter Trial Minimini. Session Type: Poster Session 246-I Date/Time: Saturday, December 4, 2004 - 06:00 PM Session Info: Poster Session: Diagnostic and Prognostic Markers in Leukemia I (6:00 PM-7:30 PM)
8.	Pavel Zak, Karel Dedic [4574] Decrease of Bone Marrow Fibrosis in Hairy Cell Leukemia (HCL) after 2-CdA Therapy. Session Type: Publication Only Session Info: Publication Only
9.	Monika Priwitzerova, Dagmar Pospisilova, Karel Indrak, Prem Ponka, Vladimir Divoky [3190] Consequences of DMT1 Mutation on Proliferation and Hemoglobinization of Erythroid Progenitors In Vitro. Session Type: Poster Session 460-III Date/Time: Monday, December 6, 2004 - 05:30 PM Session Info: Poster Session: Iron and Heme Metabolism (5:30 PM-7:00 PM)
10.	Eva Fronkova, Leona Reznickova, Katerina Muzikova, Ester Mejstrikova, Ondrej Hrusak, Martin Schrappe, Jan Stary, Jan Trka [1085] Minimal Residual Disease Detection Identifies Differences between the Risk Groups Defined by the ALL IC-BFM 2002 and the ALL-BFM 2000 Protocols. Session Type: Poster Session 239-I Date/Time: Saturday, December 4, 2004 - 06:00 PM Session Info: Poster Session: Diagnostic and Prognostic Markers in Leukemia I (6:00 PM-7:30 PM)
11.	Jan Blatny, Ladislav Dusek, Roman Smid, Miroslav Penka (Intr. by Jan Zuna) [4007] UniSeven Registry for Life Threatening Bleeding Treated with rFVIIa. Medical and Technical Background and First Output. Session Type: Publication Only Session Info: Publication Only
12.	Emanuel Necas, Martin Vokurka, Jan Krijt [3201] Red Blood Cell Hemolysis and Suppression of Erythropoiesis Strongly Upregulate mRNA for Iron Binding Lipocalin (NGAL/24p3) in the Liver. Session Type: Poster Session 471-III Date/Time: Monday, December 6, 2004 - 05:30 PM Session Info: Poster Session: Iron and Heme Metabolism (5:30 PM-7:00 PM)
13.	Thomas Lehrnbecher, Martin Zimmermann, Dirk Reinhardt, Michael Dworzak, Jan Stary, Ursula Creutzig [2911] Impact of Granulocyte Colony-Stimulating Factor during Induction Therapy in Children with Acute Myelogenous Leukemia: Results from the Prospective and Randomized Trial AML-BFM 98. Session Type: Poster Session 181-III Date/Time: Monday, December 6, 2004 - 05:30 PM Session Info: Poster Session: Clinical Intervention in Hematopoiesis (5:30 PM-7:00 PM)
14.	Nikola Hanzsch, Cornelia Eckert, Cecile Acquaviva, Eva Fronkova, Arend von Stackelberg, Udo zur Stadt, Andre Schrauder, Jan Trka, Karl Seeger, Guenter Henze, Helene Cave (Intr. by Jan Trka) [1087] Prognostic Impact of MRD in the Bone Marrow of Children at First Isolated Extramedullary Relapse of ALL. Session Type: Poster Session 241-I Date/Time: Saturday, December 4, 2004 - 06:00 PM Session Info: Poster Session: Diagnostic and Prognostic Markers in Leukemia I (6:00 PM-7:30 PM)
15.	Ester Mejstrikova, Martina Vaskova, Tomas Kalina, Jan Trka, Jan Stary, Ondrej Hrusak [1078] CD33 - but Not Myeloid Antigens in General - Heralds Poor Prognosis in Childhood B Precursor ALL. Czech Pediatric Hematology Working Group (CPH) Population-Based Study. Session Type: Poster Session 232-I Date/Time: Saturday, December 4, 2004 - 06:00 PM Session Info: Poster Session: Diagnostic and Prognostic Markers in Leukemia I (6:00 PM-7:30 PM)
16.	Petr Klement, Peng Liao, Frank Chen, Jeffrey I. Weitz [2979] No Fibrinolytic Benefit of Adjunctive Anticoagulation during Arterial Thrombolysis Induced by tPA Combined with TAFIa Inhibitor in a Rabbit Arterial Thrombosis Model. Session Type: Poster Session 249-III Date/Time: Monday, December 6, 2004 - 05:30 PM Session Info: Poster Session: Coagulation and Fibrinolysis In Vivo (5:30 PM-7:00 PM)
17.	Peter Hillmen, Aleksander B. Skotnicki, Tadeusz Robak, Jiri Mayer, Branimir Jaksic, Vojo Vukovic, Steven Weitman [2505] Preliminary Safety and Efficacy Report of a Randomized Trial of Alemtuzumab vs Chlorambucil as Front-Line Therapy in 297 Patients with Progressive B-Cell Chronic Lymphocytic Leukemia. Session Type: Poster Session 718-II Date/Time: Sunday, December 5, 2004 - 06:00 PM Session Info: Poster Session: Novel Immune Based Therapies for CLL (6:00 PM-7:30 PM)
18.	Jiri Mayer, Marta Krejci, Michael Doubek, Yvona Brychtova [1248] Pulse Cyclophosphamide (CY) in the Treatment of Acute GvHD Refratcory to Steroids. Session Type: Poster Session 402-I Date/Time: Saturday, December 4, 2004 - 06:00 PM Session Info: Poster Session: Graft-Versus-Host Disease (GvHD) (6:00 PM-7:30 PM)
19.	Janina Ratajczak, Kasia Miekus, Magda Kucia, Petr Dvorak, Mariusz Ratajczak [460] A New Mechanism of Communication between Stem Cells Involving Vertical Transfer of mRNA by Its Intracellular Delivery within Membrane-Derived Microvesicles. Session Type: Oral Session Date/Time: Monday, December 6, 2004 - 02:15 PM Session Info: Simultaneous Session: Molecular Regulation of Hematopoiesis (1:30 PM-3:00 PM)
20.	Ayami Yoshimi, Peter Bader, Susanne Matthes-Martin, Jan Starý, Thomas Klingebiel, Ulrich Duffner, Franco Locatelli, Tom Révész, Charlotte M. Niemeyer [5001] Donor Leukocyte Infusion after Stem Cell Transplantation in Patients with Juvenile Myelomonocytic Leukemia. Session Type: Publication Only Session Info: Publication Only
21.	Karel Holada, Adela Brouckova, Jan Simak, William A. Gahl, Jaroslav G. Vostal [3882] Platelet Cellular Prion Protein (PRPC) Is Associated with alpha Granules. Session Type: Publication Only Session Info: Publication Only
22.	Petr Dulicek, Pavel Zak, Jaroslav Maly, Miroslav Pecka, Vladimir Maisnar, Martin Beranek [4006] The Frequency of Venous Thromboembolism in Women with F V Leiden in Heterozygous Form from the East Bohemia Region in Association with Pregnancy and Puerperium. Session Type: Publication Only Session Info: Publication Only
23.	Michael Doubek, Marta Krejci, Yvona Brychtova, Jiri Mayer [4658] Comparison of Reduced-Intensity Conditioning Regimen and Conventional Conditioning Regimen for Allografting in Chronic Myeloid Leukemia in the First Chronic Phase. Session Type: Publication Only Session Info: Publication Only
24.	Paul B. Sinclair, Christine J. Harrison, Marie Jarosova, Letizia Foroni [2893] Balanced Rearrangements of Chromosome 6 in Acute Leukaemia: Clustered Breakpoints in 6q22-q23 and Possible Involvement of c-MYB/AHI1 in a New Recurrent Translocation, t(6;7)(q23;q31). Session Type: Poster Session 163-III Date/Time: Monday, December 6, 2004 - 05:30 PM Session Info: Poster Session: Chromosomal Rearrangements - Characterization and Arrays (5:30 PM-7:00 PM)
25.	Ursula Creutzig, Dirk Reinhardt, Joerg Ritter, Guenter Henze, Johannes Hermann, Thomas Klingebiel, Thomas Lehrnbecher, Charlotte M. Niemeyer, Alfred Reiter, Helmut Gadner, Jan Stary, Martin Zimmermann [1793] Intensification of Chemotherapy Does Not Improve Prognosis of Standard Risk Patients Undergoing Therapy for Acute Myelogenous Leukemia: Results of the Pediatric Clinical Trial AML-BFM 98. Session Type: Poster Session 6-II Date/Time: Sunday, December 5, 2004 - 06:00 PM Session Info: Poster Session: Adult and Pediatric AML - Novel Agents and Immunotherapy (6:00 PM-7:30 PM)
26.	Julia Starkova, Jozef Madzo, Tomas Kalina, Martina Vaskova, Jan Trka [1891] Histone Deacetylase Inhibitors Are Capable to Modify Leukaemia-Specific Phenotype of TEL/AML1-Positive Leukaemic Cells. Session Type: Poster Session 104-II Date/Time: Sunday, December 5, 2004 - 06:00 PM Session Info: Poster Session: Acute Lymphocytic Leukemia - Basic Biology (6:00 PM-7:30 PM)
27.	Charlotte Marie Niemeyer, Marco Zecca, Elisabeth Korthoff, Ulrich Duffner, Felix Zintl, Wolfram Ebell, Jan Starý, Dagmar Dilloo, Christina Peters, Markus Schmugge, Petr Sedlacek, Chiara Messina, Marry van Heuvel, Eva Bergstraesser, Monika Trebo, Peter Noellke, Franco Locatelli [2300] Allogeneic Stem Cell Transplantation for Children with Advanced Primary MDS: Results from the EWOG-MDS Study Group Employing a Pre-Transplant Preparative Regimen with Busulfan, Cyclophosphamide and Melphalan. Session Type: Poster Session 513-II Date/Time: Sunday, December 5, 2004 - 06:00 PM Session Info: Poster Session: Matched Related Donor Transplantation - AML/MDS and Reduced Intensity Conditioning (6:00 PM-7:30 PM)
28.	Zuzana Sieglova, Jaroslav Cermak, Sona Zilovcova, Hana Zizkova, Kyra Michalova (Intr. by Petr Jarolim) [2377] Telomere Length Reduction in Patients with Early Myelodysplastic Syndrome (MDS) Is Connected with Presence of Karyotype Abnormalities and with Shortened Survival and May Serve as an Additional Prognostic Factor. Session Type: Poster Session 590-II Date/Time: Sunday, December 5, 2004 - 06:00 PM Session Info: Poster Session: Myelodysplastic Syndromes - Translational (6:00 PM-7:30 PM)
29.	Jaroslav Cermak, Antonin Vitek, Marcela Lukasova, Kyra Michalova, Petr Cetkovsky (Intr. by Petr Jarolim) [1443] Achievement of Low or Intermediate-1 Risk Score after Combination Chemotherapy before Stem Cell Transplantation (SCT) May Be Associated with Prolonged Disease-Free Survival (DFS) in Patients with Advanced Myelodysplastic Syndrome (MDS). Session Type: Poster Session 597-I Date/Time: Saturday, December 4, 2004 - 06:00 PM Session Info: Poster Session: Myelodysplastic Syndromes - Clinical (6:00 PM-7:30 PM)
30.	Mark A. Crowther, Klement Petr, Liao Peng, Chen Frank, Berry B. Leslie, Chan K.C. Anthony [1850] Significant Differences in Neutralization of Heparin and Its Low Molecular Fragments by Protamine Sulfate: An In Vivo Study. Session Type: Poster Session 63-II Date/Time: Sunday, December 5, 2004 - 06:00 PM Session Info: Poster Session: Antithrombotic Therapy - Basic and Experimental Studies (6:00 PM-7:30 PM)
31.	Michael Pfreundschuh, Lorenz Truemper, Devinder Gill, Anders Osterborg, Ruth Pettengell, Marek Trneny, Kevin Imrie, Jan Walewski, Pier-Luigi Zinzani, Markus Loeffler [157] First Analysis of the Completed Mabthera International (MInT) Trial in Young Patients with Low-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Addition of Rituximab to a CHOP-Like Regimen Significantly Improves Outcome of All Patients with the Identification of a Very Favorable Subgroup with IPI=O and No Bulky Disease. Session Type: Oral Session Date/Time: Monday, December 6, 2004 - 07:30 AM Session Info: Simultaneous Session: Chemotherapy and Rituximab Combinations for B-Cell Non-Hodgkin's Lymphoma (7:30 AM-9:00 AM)
32.	Dirk Reinhardt, Sylke Diekamp, Joerg Ritter, Claudia Langebrake, Gudrun Fleischhack, Michael Dworzak, Jan Stary, Jochen Harbott, Wolf-Dieter Ludwig, Ursula Creutzig [401] Acute Megakaryoblastic Leukemia in Children without Downs Syndrome. Session Type: Oral Session Date/Time: Monday, December 6, 2004 - 02:30 PM Session Info: Simultaneous Session: Adult and Pediatric AML (1:30 PM-3:00 PM)
33.	Martina Vaskova, Ester Mejstrikova, Tomas Kalina, Jan Trka, Jan Stary, Ondrej Hrusak [168] Microarray Guided Flow Cytometry: CD44 and CD27 Are Extremely Powerful Discriminators of ALL Subtypes. Session Type: Oral Session Date/Time: Monday, December 6, 2004 - 08:45 AM Session Info: Simultaneous Session: Cytogenetic and Molecular Markers of Prognosis in ALL (7:30 AM-9:00 AM)
34.	Alessandro Morotti, Veronica Ullmannova, Daniela Cilloni, Francesca Messa, Manuela Messa, Ilaria Defilippi, Francesca Arruga, Sonia Carturan, Cedrik Haskovec, Enrico Gottardi, Giuseppe Saglio [4759] Over-Expression of the P65 Subunit of NF-kB and Increased DNA Binding Activity of NF-kB Is a Common Event Both in Philadelphia Positive and Negative Chronic Myeloproliferative Disorders. Session Type: Publication Only Session Info: Publication Only

Pozvání na akci

Předběžná registrace je již ukončena! Můžete se ale zaregistrovat na místě, tedy v San Diego Convention Center od čvtrtka 2.12. 12:00 hodin.Tam také můžete uhradit registrační poplatky

Registrace a online registrace
ASH rezervace ubytování je již uzavřena! Chcete-li si rezervovat ubytování v San Diegu, ASH doporučuje "ARES Housing" 1-800-350-6152. Odborný program

Web: http://www.hematology.org/